Anixa Biosciences Inc (NASDAQ: ANIX) stock enjoyed a major increase of 13.3% on 12/8/23. The shares closed at $4.08. Moreover, trading volume in this advance was exceptionally high at 737% of normal. The stock has been weak relative to the market over the last nine months but has risen 22.2% during the last week.
Current PriceTarget Research Rating
ANIX’s future returns on capital are forecasted to be below the cost of capital. Accordingly, the company is expected to continue to be a modest Value Eraser.
Anixa Biosciences has a current Value Trend Rating of F (Lowest Rating). This rating combines consistent signals from two proprietary PTR measures of a stock’s attractiveness. Anixa Biosciences has a poor Power Rating of 28 and a very low Appreciation Score of 6, resulting in the Lowest Value Trend Rating.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of F. This review will be completed in the next several days.
Be the first to comment